What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) fell 6.3% in the afternoon session after China put the company on its "unreliable entity" list, opening the door to possible sanctions.
As a result, we anticipate that this development will positively boost market sentiment toward the ILMN stock. Illumina presently has a market capitalization of $21.99 billion. The Zacks Consensus ...
With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform. Finding good stocks at good prices ...
As a result, we anticipate that this development will positively boost market sentiment toward the ILMN stock. Illumina presently has a market capitalization of $21.99 billion. The Zacks Consensus ...
Illumina, Inc. (NASDAQ:ILMN) was removed from the index. Year to date, the stock has increased around 8%, underperforming iShares Core S&P Mid-Cap ETF (NYSE:IJH). The provider of DNA sequencing and ...